To explore the status of Th1l in colorectal cancer, we first investigated the amplification of the Th1l gene in stool samples from patients with CRC (n = 97) or IBD (n = 79) and healthy controls (n = 74). This evidence concerns the gene NELFCD and colorectal carcinoma.